Swiss National Bank Invests $434,000 in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Swiss National Bank purchased a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 95,000 shares of the company's stock, valued at approximately $434,000.

Several other large investors also recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its stake in Aveanna Healthcare by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company's stock worth $7,287,000 after buying an additional 63,190 shares in the last quarter. State Street Corp lifted its holdings in shares of Aveanna Healthcare by 0.9% during the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company's stock worth $5,408,000 after acquiring an additional 9,446 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Aveanna Healthcare by 0.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock worth $2,133,000 after acquiring an additional 4,047 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its stake in Aveanna Healthcare by 297.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company's stock valued at $1,848,000 after acquiring an additional 265,969 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in Aveanna Healthcare by 21.3% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 190,570 shares of the company's stock valued at $871,000 after purchasing an additional 33,468 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on AVAH. UBS Group upped their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a "sell" rating in a report on Friday, March 14th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating for the company in a research note on Monday, January 6th.

Aveanna Healthcare Trading Down 5.3 %

Shares of NASDAQ:AVAH traded down $0.30 on Thursday, reaching $5.32. 366,272 shares of the company traded hands, compared to its average volume of 247,118. The stock has a market capitalization of $1.04 billion, a P/E ratio of -15.65 and a beta of 2.25. The business's 50-day simple moving average is $4.78 and its 200 day simple moving average is $4.97. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.11 and a 52 week high of $6.19.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64. Following the completion of the sale, the insider now owns 1,453,948 shares of the company's stock, valued at $8,011,253.48. This represents a 4.06 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders sold 67,412 shares of company stock worth $372,142 in the last ninety days. 7.80% of the stock is owned by company insiders.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.